Erratum to "Behavioral effects of the CRF1 receptor antagonist R121919 in rats selectively bred for high and low activity in the swim test" [Psychoneuroendocrinology 33(8) (2008) 1093-1101] (DOI:10.1016/j.psyneuen.2008.05.003);Behavioral effects of the CRF1 receptor antagonist R121919 in rats selectively bred for high and low activity in the swim test

Psychoneuroendocrinology

Volumn 33, Issue 8, 2008, Pages 1093-1101

  Gutman, David A ^a   Coyer, Megan J ^a   Boss Williams, Katherine A ^a   Owens, Michael J ^a   Nemeroff, Charles B ^a   Weiss, Jay M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Corticotropin releasing factor; CRF; Depression; Receptor antagonist; Selectively bred rats; Swim test

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CRF RECEPTOR TYPE 1; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FEMALE; FLOATING; FORCED SWIMMING TEST; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SELECTIVELY BRED RAT; STATISTICAL ANALYSIS; STRUGGLING; ADAPTIVE BEHAVIOR; ANIMAL; BREEDING; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG SCREENING; EXERCISE TEST; GENETICS; MOTOR ACTIVITY; RAT STRAIN; SPRAGUE DAWLEY RAT; SWIMMING;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; BEHAVIOR, ANIMAL; BREEDING; DRUG EVALUATION, PRECLINICAL; EXERCISE TEST; FEMALE; MALE; MAZE LEARNING; MOTOR ACTIVITY; PYRIMIDINES; RATS; RATS, INBRED STRAINS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SWIMMING;

EID: 49049085010     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.01.008     Document Type: Erratum

References (32)

1. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., Koob G.F., Vale W.W., and Lee K.F. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 24 (2000) 410-414
2. Cryan J.F., Valentino R.J., and Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. Rev. 29 (2005) 547-569
3. Detke M.J., Rickels M., and Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121 (1995) 66-72
4. Dunn A.J., and Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res. Brain Res. Rev. 15 (1990) 71-100
5. Frank E., Salchner P., Aldag J.M., Salome N., Singewald N., Landgraf R., and Wigger A. Genetic predisposition to anxiety-related behavior determines coping style, neuroendocrine responses, and neuronal activation during social defeat. Behav. Neurosci. 120 (2006) 60-71
6. Funk C.K., Zorrilla E.P., Lee M.J., Rice K.C., and Koob G.F. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol. Psychiatry 61 (2007) 78-86
7. Griebel G., Simiand J., Steinberg R., Jung M., Gully D., Roger P., Geslin M., Scatton B., Maffrand J.P., and Soubrie P. 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders. J. Pharmacol. Exp. Ther. 301 (2002) 333-345
8. Gutman D.A., Owens M.J., Skelton K.H., Thrivikraman K.V., and Nemeroff C.B. The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. J. Pharmacol. Exp. Ther. 304 (2003) 874-880
9. Heinrichs S.C., De Souza E.B., Schulteis G., Lapsansky J.L., and Grigoriadis D.E. Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist. Neuropsychopharmacology 27 (2002) 194-202
10. 1 antagonist, CP-154,526, in rodent models of anxiety and depression. Pharmacol. Biochem. Behav. 86 (2007) 431-440
11. Jutkiewicz E.M., Wood S.K., Houshyar H., Hsin L.W., Rice K.C., and Woods J.H. The effects of CRF antagonists, antalarmin, CP-154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats. Psychopharmacology 180 (2005) 215-223
12. Keck M.E., Welt T., Wigger A., Renner U., Engelmann M., Holsboer F., and Landgraf R. The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats. Eur. J. Neurosci. 13 (2001) 373-380
13. Kishimoto T., Radulovic J., Radulovic M., Lin C.R., Schrick C., Hooshmand F., Hermanson O., Rosenfeld M.G., and Spiess J. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 24 (2000) 415-419
14. Overstreet D.H. The Flinders Sensitive Line rats: a genetic animal model of depression. Neurosci. Biobehav. Rev. 17 (1993) 51-68
15. Overstreet D.H. Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists. Behav. Genet. 32 (2002) 335-348
16. 1 receptor antagonist SSR125543 in an animal model of depression. Eur. J. Pharmacol. 497 (2004) 49-53
17. Owens M.J., and Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43 (1991) 425-473
18. Pelleymounter M.A., Joppa M., Ling N., and Foster A.C. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress. J. Pharmacol. Exp. Ther. 302 (2002) 145-152
19. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47 (1978) 379-391
20. Porsolt R.D., Bertin A., and Jalfre M. Behavioural despair" in rats and mice: strain differences and the effects of imipramine. Eur. J. Pharmacol. 51 (1978) 291-294
21. 2 binding sites in adult rat brain. Neuropsychopharmacology 17 (1997) 308-316
22. Smagin G.N., and Dunn A.J. The role of CRF receptor subtypes in stress-induced behavioural responses. Eur. J. Pharmacol. 405 (2000) 199-206
23. Steckler T., and Holsboer F. Corticotropin-releasing hormone receptor subtypes and emotion. Biol. Psychiatry 46 (1999) 1480-1508
24. Strome E.M., Wheler G.H., Higley J.D., Loriaux D.L., Suomi S.J., and Doudet D.J. Intracerebroventricular corticotropin-releasing factor increases limbic glucose metabolism and has social context-dependent behavioral effects in nonhuman primates. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 15749-15754
25. Sutton R.E., Koob G.F., Le Moal M., Rivier J., and Vale W. Corticotropin releasing factor produces behavioural activation in rats. Nature 297 (1982) 331-333
26. Takahashi L.K. Role of CRF(1) and CRF(2) receptors in fear and anxiety. Neurosci. Biobehav. Rev. 25 (2001) 627-636
27. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M., Stalla G.K., Blanquet V., Steckler T., Holsboer F., and Wurst W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 19 (1998) 162-166
28. Valdez G.R., Inoue K., Koob G.F., Rivier J., Vale W., and Zorrilla E.P. Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Res. 943 (2002) 142-150
29. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., and Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428 (2000) 191-212
30. Weiss J.M., Cierpial M.A., and West C.H. Selective breeding of rats for high and low motor activity in a swim test: toward a new animal model of depression. Pharmacol. Biochem. Behav. 61 (1998) 49-66
31. West C., McCurdy P., Bonsall R., and Weiss J. Behavioral and biochemical responses to stress in rats selectively bred for swim test activity. Soc. Neurosci. (1993)
32. Zobel A.W., Nickel T., Kunzel H.E., Ackl N., Sonntag A., Ising M., and Holsboer F. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J. Psychiatr. Res. 34 (2000) 171-181